by Market Overview:
The erectile dysfunction treatment market consists of drugs that help treat erectile dysfunction, commonly known as impotence. Erectile dysfunction occurs when a man cannot get or maintain an erection firm enough for sexual intercourse. The most common drugs used in erectile dysfunction treatment include sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra). These drugs improve erectile function by increasing blood flow to the penis during sexual stimulation. They work by inhibiting an enzyme called phosphodiesterase type 5 (PDE5), which prevents blood flow to the penis. Other treatment options include penile pumps, penile injections, and penile prosthesis surgery.
Market Key Trends:
One of the key trends in the erectile dysfunction treatment market is the growing preference for generic drugs over branded drugs due to their lower cost. Expiry of patents for popular drugs like Viagra, Cialis and Levitra has led to the availability of inexpensive generic versions. This has enabled wider access to treatment and boosted the erectile dysfunction treatment market. Furthermore, increasing awareness about erectile dysfunction and availability of treatment options through online channels and healthcare programs are also contributing to market growth.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate due to the presence of well-established players and requirement of high R&D investment and regulatory approvals.
Bargaining power of buyers: The bargaining power of buyers is low due to the presence of a large patient pool suffering from erectile dysfunction.
Bargaining power of suppliers: The bargaining power of suppliers is moderate due to the availability of substitutes and differentiation in products.
Threat of new substitutes: The threat of new substitutes is moderate due to the continuous innovation and advancement in treatment options.
Competitive rivalry: High due to presence of many regional and global players.
Key Takeaways
The Global Erectile Dysfunction Treatment Market Demand is expected to witness high growth, exhibiting CAGR of 7.6% over the forecast period, due to increasing prevalence of erectile dysfunction among aging population.
Regional analysis:
North America dominated the market and is expected to maintain its dominance during the forecast period. This is attributed to increased awareness regarding erectile dysfunction and easy availability of treatment options. Asia Pacific is expected to grow at fastest CAGR owing to rising geriatric population, growing economies, and improving healthcare infrastructure.
Key players:
Key players operating in the Erectile Dysfunction Treatment market are Mangoceuticals, Inc, Futura Medical, CURE Pharmaceutical Holding Corp, Glenmark Pharmaceuticals Ltd, Mylan Pharmaceuticals Inc., Boston Scientific, Cipla Ltd , Pfizer Inc., Coloplast CORP, Eli Lily & Co, Gust Inc, Altera, Promedon, Dr. Reddys Laboratories Ltd, Bayer Pharma AG, and Reflexonic LLC. Mylan Pharmaceuticals Inc., Pfizer Inc. and Eli Lily & Co account for major market share.
Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
